TrialNaunyn-Schmiedeberg's archives of pharmacology2018

A population pharmacodynamic model characterizing neutropenia associated with pegylated interferon alpha 2-a therapy in patients with chronic hepatitis C viral infection.

Mohammad I Saleh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.